IMMUNE-MEDIATED MYELITIS

IMMUNE-MEDIATED MYELITIS was reported 26 times

IMMUNE-MEDIATED MYELITIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 OBECABTAGENE AUTOLEUCEL 1 0.0141
1 VONOPRAZAN FUMARATE 3 0.0004
2 HYDROCORTISONE SODIUM SUCCINATE 1 0.0003
3 PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF 1 0.0002
4 IPILIMUMAB 7 0.0002
5 CILTACABTAGENE AUTOLEUCEL 1 0.0002
6 PEMBROLIZUMAB 11 0.0001
7 LENVATINIB 3 0.0001
8 VEMURAFENIB 1 0.0001
9 NIVOLUMAB 8 0.0001
10 NAPROXEN SODIUM 220MG 1 0.0001
11 URSOSIOL 1 0.0001
12 DABRAFENIB 1 0.0000
13 URSODIOL 1 0.0000
14 TRAMETINIB 1 0.0000
15 CISPLATIN 3 0.0000
16 PEMETREXED DISODIUM 1 0.0000
17 ATEZOLIZUMAB 1 0.0000
18 MEPOLIZUMAB 1 0.0000
19 NAPROXEN SODIUM 2 0.0000
20 INFLIXIMAB 3 0.0000
21 SODIUM CHLORIDE TABLET 1 0.0000
22 SODIUM CHLORIDE TABLETS 1 0.0000
23 FLUOROURACIL CREAM, 0.5% 1 0.0000
24 FLUOROURACIL 1 0.0000
25 SODIUM CHLORIDE 1 0.0000
26 ROSUVASTATIN 1 0.0000
27 PACLITAXEL 1 0.0000
28 ACYCLOVIR 1 0.0000
29 FAMOTIDINE 1 0.0000
30 CARBOPLATIN 1 0.0000
31 CELECOXIB 1 0.0000
32 DIPHENHYDRAMINE HYDROCHLORIDE 1 0.0000
33 ACETAMINOPHEN 2 0.0000
34 PREDNISONE 1 0.0000